Study of ALK-001 on the Progression of Stargardt Disease
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Associated Retina Consultants
Phoenix, Arizona, United States
Benjamin Bakall, MD, PhDRecruiting - Vitreo Retinal Associates
Gainesville, Florida, United States
Christine Kay, MDNot, yet, recruiting - Erie Retina Research
Erie, Pennsylvania, United States
David Almeida, MD, MBA, PhDRecruiting - Retina Foundation of the Southwest
Dallas, Texas, United States
Karl Csaky, MD, PhDRecruiting - Star Retina
Fort Worth, Texas, United States
Courtney Crawford, MD, FACSRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2026
- Primary completion
- 31 Oct 2029
- Completion
- 31 Dec 2030
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 230
- Registry id
- NCT07419334
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.